AI-informed virtual assistant to help solve ‘stubborn problems,’ says Saama

By Melissa Fassbender contact

- Last updated on GMT

DaLIA is Saama’s new Deep Learning Intelligent Assistant. (Image: Getty/chombosan)
DaLIA is Saama’s new Deep Learning Intelligent Assistant. (Image: Getty/chombosan)
Saama has launched a set of artificial intelligence (AI) capabilities designed to understand "typical life science domain questions" to better support clinical trial planning, feasibility, and conduct.

The new “deep learning intelligent assistant” – DaLIA – leverages natural language processing (NLP) and natural language understanding (NLU) to enhance Saama’s ​existing suite of clinical trial solutions, according to the company. The so-called virtual assistant is an alternative to the keyboard and mouse.

“DaLIA is not only the gateway to robust conversational experiences with clinical trial data but the gateway to key AI enabled functionality within Saama’s Life Science Analytics Cloud (LSAC),”​ said Malaikannan Sankarasubbu, VP of AI Research, Saama Technologies.

The company’s LSAC is designed to address challenges including trial feasibility and planning, study conduct, as well as preclinical operations, such as adverse drug event and drug-drug interactions.

“DaLIA is domain and context aware which is significant,”​ Sankarasubbu told us. “DaLIA will keep track of the conversation you are having with it so that you can ask subtending questions without having to prefix it for context. DaLIA is designed to understand typical life science domain questions.”

Saama is currently piloting DaLIA at multiple pharmaceutical customers and will continue to implement the technology throughout 2018.

Sankarasubbu said: “Saama does not believe in using AI for the sake of using AI. Saama’s use of AI is focused and targeted at solving stubborn problems the industry has had for years.”

Related news

Show more

Related products

show more

Vaccine Innovation in the Era of COVID19

Vaccine Innovation in the Era of COVID19

Covance Patient Safety | 01-Oct-2020 | Sponsored Link

During this time of worldwide crisis, there is an increasing demand for the acceleration of a vaccination for COVID19. Regardless of the great recent advancements...

What to consider when working with CRFs

What to consider when working with CRFs

Formedix | 21-Sep-2020 | Technical / White Paper

For a study to be successful, data collected must be correct and complete. To be correct and complete, forms must be well planned with meticulous attention...

Covance Touchless Drug and Device Vigilance Vision

Covance Touchless Drug and Device Vigilance Vision

Covance Patient Safety | 01-Sep-2020 | Data Sheet

Automation tools enable organizations to identify patterns in structured and unstructured data and facilitate automation of the entire product vigilance...

Related suppliers

Follow us

Products

View more

Webinars